Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

[Advances in the pathophysiology and management of infections in the acute phase of stroke.]

PMID: 22652018
Journal: MEDICINA CLINICA
Year: 2012
Reference: Med Clin (Barc). 2012 Dec 15;139(15):681-7. doi: 10.1016/j.medcli.2012.03.014. Epub 2012 May 29.
Impact factor: 1.385
Publication type: Review in national publication
Authors: , , et al.
DOI: 10.1016/j.medcli.2012.03.014

[Advances in the pathophysiology and management of infections in the acute phase of stroke.]

PMID: 22652018
Journal: MEDICINA CLINICA
Year: 2012
Reference: Med Clin (Barc). 2012 Dec 15;139(15):681-7. doi: 10.1016/j.medcli.2012.03.014. Epub 2012 May 29.
Impact factor:
Publication type: Review in national publication
Authors: ; ; et al.
DOI: 10.1016/j.medcli.2012.03.014

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

PMID: 21976387
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 May;23(5):1130-7. Epub 2011 Oct 4.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1093/annonc/mdr432

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

PMID: 32018567
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 May;23(5):1130-1137. doi: 10.1093/annonc/mdr432. Epub 2019 Dec 4.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: Cortes, J, Calvo, V, Ramirez-Merino, N, O'Shaughnessy, J, Brufsky, A, Robert, N, Vidal, M, Munoz, E, Perez, J, Dawood, S et al.
DOI: 10.1093/annonc/mdr432

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

PMID: 21976387
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 May;23(5):1130-7. Epub 2011 Oct 4.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1093/annonc/mdr432

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

PMID: 32018567
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 May;23(5):1130-1137. doi: 10.1093/annonc/mdr432. Epub 2019 Dec 4.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, J; Bellet, M; Brufsky, A; Calvo, V; Cortes, J; Dawood, S; Di Cosimo, S; Gonzalez-Martin, A; Llombart, A; Miles, D et al.
DOI: 10.1093/annonc/mdr432

Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.

PMID: 22520341
Journal: LEUKEMIA RESEARCH
Year: 2012
Reference: Leuk Res. 2012 Aug;36(8):990-7. doi: 10.1016/j.leukres.2012.03.019. Epub 2012 Apr 19.
Impact factor: 2.923
Publication type: Paper in international publication
Authors: Nomdedeu, J, Hoyos, M, Carricondo, M, Esteve, J, Bussaglia, E, Estivill, C, Ribera, J M, Duarte, R, Salamero, O, Gallardo, D et al.
DOI: 10.1016/j.leukres.2012.03.019

Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.

PMID: 22520341
Journal: LEUKEMIA RESEARCH
Year: 2012
Reference: Leuk Res. 2012 Aug;36(8):990-7. doi: 10.1016/j.leukres.2012.03.019. Epub 2012 Apr 19.
Impact factor:
Publication type: Paper in international publication
Authors: Aventin, A; Brunet, S; Bussaglia, E; Carricondo, M; Duarte, R; Esteve, J; Estivill, C; Gallardo, D; Hoyos, M; Nomdedeu, J et al.
DOI: 10.1016/j.leukres.2012.03.019

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants.

PMID: 22669510
Journal: JOURNAL OF MOLECULAR NEUROSCIENCE
Year: 2012
Reference: J Mol Neurosci. 2012 Sep;48(1):245-7. doi: 10.1007/s12031-012-9820-7. Epub 2012 Jun 6.
Impact factor: 2.504
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1007/s12031-012-9820-7

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants.

PMID: 22669510
Journal: JOURNAL OF MOLECULAR NEUROSCIENCE
Year: 2012
Reference: J Mol Neurosci. 2012 Sep;48(1):245-7. doi: 10.1007/s12031-012-9820-7. Epub 2012 Jun 6.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1007/s12031-012-9820-7

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

PMID: 23122650
Journal: LANCET
Year: 2012
Reference: Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.
Impact factor: 38.278
Publication type: Paper in international publication
Authors: Panzara, Michael A, Compston, D Alastair S, Arnold, Doug, Cohen, Jeffrey A, Coles, Alasdair, Compston, Alastair, Confavareux, Christian, Fox, Edward, Hartung, Hans-Peter, Oyuela, Pedro et al.
DOI: 10.1016/S0140-6736(12)61768-1

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

PMID: 23122650
Journal: LANCET
Year: 2012
Reference: Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.
Impact factor:
Publication type: Paper in international publication
Authors: Achiron, Anat; Agius, Mark A; Antel, Jack; Antonelli, Licia; Arnold, Doug; Arnold, Douglas L; Ayotte, Charles; Ayuso, Guillermo Izquierdo; Barantsevich, Evgeniy R; Barkhof, Frederik et al.
DOI: 10.1016/S0140-6736(12)61768-1

All-cause mortality in treated HIV-infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

PMID: 22493325
Journal: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Year: 2012
Reference: Int J Epidemiol. 2012 Apr;41(2):433-45. Epub 2011 Nov 28.
Impact factor: 6.414
Publication type: Paper in international publication
Authors: Bucher, Heiner, Lewden, Charlotte, Bouteloup, Vincent, de Wit, Stephane, Sabin, Caroline, Mocroft, Amanda, Wasmuth, Jan Christian, van Sighem, Ard, Kirk, Ole, Obel, Niels et al.
DOI: 10.1093/ije/dyr164

All-cause mortality in treated HIV-infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

PMID: 22493325
Journal: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Year: 2012
Reference: Int J Epidemiol. 2012 Apr;41(2):433-45. Epub 2011 Nov 28.
Impact factor:
Publication type: Paper in international publication
Authors: Antinori, Andrea; Antinori, Andrea; Battegay, Manuel; Battegay, Manuel; Bohlius, Julia; Bouteloup, Vincent; Bouteloup, Vincent; Bouteloup, Vincent; Brockmeyer, Norbert; Bucher, Heiner et al.
DOI: 10.1093/ije/dyr164

alpha1-Antitrypsin in Fibromyalgia: Results of a Randomized, Placebo-Controlled, Double-Blind and Crossover Pilot Trial.

PMID: 22190533
Journal: Musculoskeletal care
Year: 2012
Reference: Musculoskeletal Care. 2012 Sep;10(3):178-83. doi: 10.1002/msc.1000. Epub 2011 Dec 22.
Impact factor:
Publication type: Letter or abstract
Authors: , , , , et al.
DOI: 10.1002/msc.1000

alpha1-Antitrypsin in Fibromyalgia: Results of a Randomized, Placebo-Controlled, Double-Blind and Crossover Pilot Trial.

alpha-synuclein phosphorylation and truncation are normal events in the adult human brain.

PMID: 22079575
Journal: NEUROSCIENCE
Year: 2012
Reference: Neuroscience. 2012 Jan 3;200:106-19. Epub 2011 Oct 29.
Impact factor: 3.38
Publication type: Paper in international publication
Authors: Muntane, G, Ferrer, I, Martinez-Vicente, M et al.
DOI: 10.1016/j.neuroscience.2011.10.042

alpha-synuclein phosphorylation and truncation are normal events in the adult human brain.

PMID: 22079575
Journal: NEUROSCIENCE
Year: 2012
Reference: Neuroscience. 2012 Jan 3;200:106-19. Epub 2011 Oct 29.
Impact factor:
Publication type: Paper in international publication
Authors: Ferrer, I; Martinez-Vicente, M; Muntane, G et al.
DOI: 10.1016/j.neuroscience.2011.10.042

ALS untangled No. 17: "when ALS is lyme".

PMID: 22873562
Journal: Amyotrophic Lateral Sclerosis
Year: 2012
Reference: Amyotroph Lateral Scler. 2012 Sep;13(5):487-91. Epub 2012 Aug 8.
Impact factor: 3.091
Publication type: Review in international publication
Authors: Levine, Todd, Bedlack, Richard, Hardiman, Orla, Heiman-Patterson, Terry, Gutmann, Laurie, Bromberg, Mark, Ostrow, Lyle, Carter, Gregory, Kabashi, Edor, Bertorini, Tulio et al.
DOI: 10.3109/17482968.2012.717796

ALS untangled No. 17: "when ALS is lyme".

PMID: 22873562
Journal: Amyotrophic Lateral Sclerosis
Year: 2012
Reference: Amyotroph Lateral Scler. 2012 Sep;13(5):487-91. Epub 2012 Aug 8.
Impact factor:
Publication type: Review in international publication
Authors: Andersen, Peter; Armon, Carmel; Atassi, Nazem; Baker, Jon; Bedlack, Richard; Benatar, Michael; Bertorini, Tulio; Bowser, Robert; Boylan, Kevin; Bromberg, Mark et al.
DOI: 10.3109/17482968.2012.717796

ALSUntangled 15: coconut Oil.

PMID: 22471904
Journal: Amyotrophic Lateral Sclerosis
Year: 2012
Reference: Amyotroph Lateral Scler. 2012 May;13(3):328-30. doi: 10.3109/17482968.2012.671629. Epub 2012 Apr 3.
Impact factor: 3.091
Publication type: Editorail in international publication
Authors: Weiss, Michael, Bedlack, Richard, Hardiman, Orla, Bertorini, Tulio, Mozaffar, Tahseen, Andersen, Peter, Dietz, Jeff, Gamez, Josep, Dimachkie, Mazen, Wang, Yunxia et al.
DOI: 10.3109/17482968.2012.671629

ALSUntangled 15: coconut Oil.

PMID: 22471904
Journal: Amyotrophic Lateral Sclerosis
Year: 2012
Reference: Amyotroph Lateral Scler. 2012 May;13(3):328-30. doi: 10.3109/17482968.2012.671629. Epub 2012 Apr 3.
Impact factor:
Publication type: Editorail in international publication
Authors: Andersen, Peter; Armon, Carmel; Atassi, Nazem; Baker, Jon; Bedlack, Richard; Benatar, Michael; Bertorini, Tulio; Bowser, Robert; Boylan, Kevin; Caress, James et al.
DOI: 10.3109/17482968.2012.671629

ALSUntangled No. 14: Mototab.

PMID: 22214359
Journal: Amyotrophic Lateral Sclerosis
Year: 2012
Reference: Amyotroph Lateral Scler. 2012 Jan;13(1):161-4.
Impact factor: 3.091
Publication type: Paper in international publication
Authors: Baker, Jon, Atassi, Nazem, Forshew, Dallas, Ravits, John, Conwit, Robin, Jackson, Carlayne, Sherman, Alex, Dalton, Kate, Tindall, Katherine, Gonzalez, Ginna et al.
DOI: 10.3109/17482968.2012.645410

ALSUntangled No. 14: Mototab.

PMID: 22214359
Journal: Amyotrophic Lateral Sclerosis
Year: 2012
Reference: Amyotroph Lateral Scler. 2012 Jan;13(1):161-4.
Impact factor:
Publication type: Paper in international publication
Authors: Andersen, Peter; Armon, Carmel; Atassi, Nazem; Baker, Jon; Bedlack, Richard; Benatar, Michael; Bertorini, Tulio; Bowser, Robert; Boylan, Kevin; Caress, James et al.
DOI: 10.3109/17482968.2012.645410

Publications

Publications searcher

[Advances in the pathophysiology and management of infections in the acute phase of stroke.]

[Advances in the pathophysiology and management of infections in the acute phase of stroke.]

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.

Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants.

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants.

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

All-cause mortality in treated HIV-infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

All-cause mortality in treated HIV-infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

alpha1-Antitrypsin in Fibromyalgia: Results of a Randomized, Placebo-Controlled, Double-Blind and Crossover Pilot Trial.

alpha1-Antitrypsin in Fibromyalgia: Results of a Randomized, Placebo-Controlled, Double-Blind and Crossover Pilot Trial.

alpha-synuclein phosphorylation and truncation are normal events in the adult human brain.

alpha-synuclein phosphorylation and truncation are normal events in the adult human brain.

ALS untangled No. 17: "when ALS is lyme".

ALS untangled No. 17: "when ALS is lyme".

ALSUntangled 15: coconut Oil.

ALSUntangled 15: coconut Oil.

ALSUntangled No. 14: Mototab.

ALSUntangled No. 14: Mototab.

Patronage:

Collaborating:

Accreditations: